Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enzyme, Exposed
Health literacy and patient safety: help patients understand
Phase II Study Showed Ocrelizumab Maintained Significant Reduction in Disease Activity for Multiple Sclerosis Patients for Almost Two Years
MS May Impair Cerebellar Regional Functional Connectivity
Few MS Patients Fail to Receive Disease-Modifying Therapy
CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis.
Channeling MS
Consent guidance: patients and doctors making decisions together
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
MS Research Roundup: December 2, 2014
Experimental models of multiple sclerosis.
Neuromyelitis optica: not a multiple sclerosis variant.
Core Value of Amyloids
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.
Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
A Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis
Body temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.
A Study of Ocrelizumab in Comparison with Interferon Beta 1a (Rebif) in Patients with Relapsing Multiple Sclerosis
MS Patient, Ph.D.: Patience, the Rusty Adjective
MS Research Roundup: May 20, 2014
Dietary patterns not associated with the risk of multiple sclerosis
ACTRIMS Forum 2016
Multiple sclerosis and nutrition.
MS Research Roundup: February 7, 2014
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »
